{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:25:26Z","timestamp":1786296326728,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY026572"],"award-info":[{"award-number":["EY026572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH NEI P30 EY010572"],"award-info":[{"award-number":["NIH NEI P30 EY010572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008143","name":"Oregon National Primate Research Center","doi-asserted-by":"publisher","award":["OD P51 OD011092"],"award-info":[{"award-number":["OD P51 OD011092"]}],"id":[{"id":"10.13039\/100008143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019792","name":"William H. and Mary L. Bauman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajo.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T09:56:02Z","timestamp":1611482162000},"page":"226-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Identifying RNA Biomarkers and Molecular Pathways Involved in Multiple Subtypes of Uveitis"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-6736","authenticated-orcid":false,"given":"James T.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-2322","authenticated-orcid":false,"given":"Robert P.","family":"Searles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-2890","authenticated-orcid":false,"given":"Suzanne S.","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-7474","authenticated-orcid":false,"given":"Amr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Arepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-3176","authenticated-orcid":false,"given":"Michael A.","family":"Paley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Hassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert T.","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Conrady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthyda","family":"Keath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-604X","authenticated-orcid":false,"given":"Claire","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Planck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-4072","authenticated-orcid":false,"given":"Dongseok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.01.007_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2021.01.007_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/11537460-000000000-00000","article-title":"Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trials","volume":"30","author":"Schiff","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajo.2021.01.007_bib0004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09546634.2017.1422591","article-title":"A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12\/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis","volume":"29","author":"Bilal","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ajo.2021.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ajo.2021.01.007_bib0006","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009742.2017.1390605","article-title":"Secukinumab after anti-tumour necrosis factor-alpha therapy: a phase III study in active rheumatoid arthritis","volume":"47","author":"Dokoupilova","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/annrheumdis-2016-210002","article-title":"Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis","volume":"76","author":"Miloslavsky","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2021.01.007_bib0008","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0009","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2021.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2021.01.007_bib0011","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archopht.1984.01040030450024","article-title":"Immunologic analysis of intraocular mononuclear cell infiltrates in uveitis","volume":"102","author":"Kaplan","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0012","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/eye.2012.10","article-title":"Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma","volume":"26","author":"Pulido","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2021.01.007_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2020.09.012","article-title":"Revising the diagnosis of idiopathic uveitis by peripheral blood transcriptomics","volume":"222","author":"Rosenbaum","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0014","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.181.7.5147","article-title":"Gene expression profiling in autoimmune noninfectious uveitis disease","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0015","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/s41598-020-62801-6","article-title":"RNA-Seq of human whole blood: evaluation of globin RNA depletion on Ribo-Zero library method","volume":"10","author":"Harrington","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2021.01.007_bib0016","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0017","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0018","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajo.2021.01.007_bib0020","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gky962","article-title":"New approach for understanding genome variations in KEGG","volume":"47","author":"Kanehisa","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajo.2021.01.007_bib0021","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci"},{"key":"10.1016\/j.ajo.2021.01.007_bib0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/14397595.2014.887988","article-title":"Intercellular adhesion molecule-1 polymorphisms in patients with Behcet disease: a meta-analysis","volume":"24","author":"Zou","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0023","first-page":"2563","article-title":"Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis","volume":"42","author":"Becker","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.01.007_bib0024","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1167\/iovs.10-5896","article-title":"Treatment of inflammatory macular edema with humanized anti-CD11a antibody therapy","volume":"52","author":"Faia","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.01.007_bib0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.0b013e3182478d4b","article-title":"Fatal PML associated with efalizumab therapy: insights into integrin alphaLbeta2 in JC virus control","volume":"78","author":"Schwab","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ajo.2021.01.007_bib0026","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s10067-020-05043-1","article-title":"The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs","volume":"39","author":"Zhao","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/1744666X.2020.1729129","article-title":"Correlation of serum protein biomarkers with disease activity in psoriatic arthritis","volume":"16","author":"Boyd","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0028","doi-asserted-by":"crossref","first-page":"e45801","DOI":"10.1371\/journal.pone.0045801","article-title":"Interleukin 27 induces the expression of complement factor H (CFH) in the retina","volume":"7","author":"Amadi-Obi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2021.01.007_bib0029","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.humimm.2007.06.002","article-title":"Associations between interferon regulatory factor-1 polymorphisms and Behcet's disease","volume":"68","author":"Lee","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ajo.2021.01.007_bib0031","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4049\/jimmunol.155.8.4090","article-title":"Paradoxical effects of interleukin-10 in endotoxin-induced uveitis","volume":"155","author":"Rosenbaum","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0032","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/rheumatology\/kez682","article-title":"Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis","volume":"59","author":"Petrasca","year":"2020","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.ajo.2021.01.007_bib0033","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4049\/jimmunol.1701649","article-title":"NK cells require cell-extrinsic and -intrinsic TYK2 for full functionality in tumor surveillance and antibacterial immunity","volume":"202","author":"Simonovic","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0034","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13543776.2019.1567713","article-title":"Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018)","volume":"29","author":"He","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.ajo.2021.01.007_bib0035","doi-asserted-by":"crossref","first-page":"112152","DOI":"10.18632\/oncotarget.22899","article-title":"MEF2 signaling and human diseases","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajo.2021.01.007_bib0036","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1167\/iovs.17-21767","article-title":"Molecular pathway to protection from age-dependent photoreceptor degeneration in Mef2 deficiency","volume":"58","author":"Nagar","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.01.007_bib0037","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/gtc.12233","article-title":"Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells","volume":"20","author":"Omori","year":"2015","journal-title":"Genes Cells"},{"key":"10.1016\/j.ajo.2021.01.007_bib0038","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1101\/gad.290619.116","article-title":"MEF2 transcription factors are key regulators of sprouting angiogenesis","volume":"30","author":"Sacilotto","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajo.2021.01.007_bib0039","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1002\/jcb.26078","article-title":"Aberrantly expressed long non-coding RNAs in CD8(+) T cells response to active tuberculosis","volume":"118","author":"Fu","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajo.2021.01.007_bib0040","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.4049\/jimmunol.164.5.2807","article-title":"The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen","volume":"164","author":"Warren","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0041","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/sji.12011","article-title":"Minor histocompatibility antigen UTY as target for graft-versus-leukemia and graft-versus-haematopoiesis in the canine model","volume":"77","author":"Bund","year":"2013","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ajo.2021.01.007_bib0042","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2018.00504","article-title":"Subretinal injection of HY peptides induces systemic antigen-specific inhibition of effector CD4(+) and CD8(+) T-cell responses","volume":"9","author":"Vendomele","year":"2018","journal-title":"Front Immunol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:43:12Z","timestamp":1762080192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"alternative-id":["S0002939421000271"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.01.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying RNA Biomarkers and Molecular Pathways Involved in Multiple Subtypes of Uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}